Report Highlights
Orthobiologics Market – Scope of Report
TMR’s report on the global orthobiologics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global orthobiologics market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global orthobiologics market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the orthobiologics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global orthobiologics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global orthobiologics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global orthobiologics market.
The report delves into the competitive landscape of the global orthobiologics market. Key players operating in the global orthobiologics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global orthobiologics market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market orthobiologics.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
- Company websites, presentations, annual reports, white papers, technical paper, product brochure
- Internal and external proprietary databases and relevant patents
- National government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
- Industry Sources:
- WorldWideScience.org
- Elsevier, Inc.
- National Institutes of Health (NIH)
- PubMed
- NCBI
- Department of Health Care Service
- Trade Data Sources
- Trade Map
- UN Comtrade
- Trade Atlas
- Company Information
- OneSource Business Browser
- Hoover’s
- Factiva
- Bloomberg
- Mergers & Acquisitions
- Thomson Mergers & Acquisitions
- MergerStat
- Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
- Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
- Helps in validating and strengthening secondary research findings
- Further develops the analysis team’s expertise and market understanding
- Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
- Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
- Purchasing/Sourcing managers, technical personnel, distributors
- Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
- Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
- Advanced Oncotherapy PLC
- Danfysik A/S
- Hitachi, Ltd.
- IBA Worldwide
- Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
- Table 1 : Global Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
- Table 2 : Global Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
- Table 3 : Global Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
- Table 4 : Global Orthobiologics Market Size (US$ Mn) Forecast, by Region, 2017–2031
- Table 5 : North America Orthobiologics Market Size (US$ Mn) Forecast, by Country, 2017–2031
- Table 6 : North America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
- Table 7 : North America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
- Table 8 : North America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
- Table 9 : Europe Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 10 : Europe Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
- Table 11 : Europe Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
- Table 12 : Europe Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
- Table 13 : Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 14 : Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
- Table 15 : Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
- Table 16 : Asia Pacific Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
- Table 17 : Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 18 : Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
- Table 19 : Latin America Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
- Table 20 : Latin America Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
- Table 21 : Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 22 : Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Product, 2017–2031
- Table 23 : Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by Application, 2017–2031
- Table 24 : Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
- Figure 1 : Global Orthobiologics Market Size (US$ Mn) and Distribution (%), by Region, 2018 and 2031
- Figure 2 : Global Orthobiologics Market Revenue (US$ Mn), by Product, 2021
- Figure 3 : Global Orthobiologics Market Value Share, by Product, 2021
- Figure 4 : Global Orthobiologics Market Value Share, by Application, 2021
- Figure 5 : Global Orthobiologics Market Value Share, by End-user, 2021
- Figure 6 : Global Orthobiologics Market Value Share, by Region, 2021
- Figure 7 : Global Orthobiologics Market Value (US$ Mn) Forecast, 2017–2031
- Figure 8 : Global Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
- Figure 9 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bone Morphogenetic Proteins, 2017–2031
- Figure 10 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Demineralized Bone Matrix, 2017–2031
- Figure 11 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Synthetic Bone Substitutes, 2017–2031
- Figure 12 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Viscosupplements, 2017–2031
- Figure 13 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Allografts, 2017–2031
- Figure 14 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stem Cell, 2017–2031
- Figure 15 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031
- Figure 16 : Global Orthobiologics Market Attractiveness Analysis, by Product, 2022-2031
- Figure 17 : Global Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
- Figure 18 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Spinal Fusion, 2017–2031
- Figure 19 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Trauma Repair, 2017–2031
- Figure 20 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Restorative Surgery, 2017–2031
- Figure 21 : Global Orthobiologics Market Attractiveness Analysis, by Application, 2022-2031
- Figure 22 : Global Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 23 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2031
- Figure 24 : Global Orthobiologics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Orthopedic Clinics, 2017–2031
- Figure 25 : Global Orthobiologics Market Attractiveness Analysis, by End-user, 2022-2031
- Figure 26 : Global Orthobiologics Market Value Share Analysis, by Region, 2017 and 2031
- Figure 27 : Global Orthobiologics Market Attractiveness Analysis, by Region, 2022-2031
- Figure 28 : North America Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
- Figure 29 : North America Orthobiologics Market Attractiveness Analysis, by Country, 2017–2031
- Figure 30 : North America Orthobiologics Market Value Share Analysis, by Country, 2017 and 2031
- Figure 31 : North America Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
- Figure 32 : North America Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
- Figure 33 : North America Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 34 : North America Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031
- Figure 35 : North America Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031
- Figure 36 : North America Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031
- Figure 37 : Europe Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
- Figure 38 : Europe Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
- Figure 39 : Europe Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
- Figure 40 : Europe Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
- Figure 41 : Europe Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
- Figure 42 : Europe Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 43 : Europe Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031
- Figure 44 : Europe Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031
- Figure 45 : Europe Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031
- Figure 46 : Asia Pacific Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
- Figure 47 : Asia Pacific Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
- Figure 48 : Asia Pacific Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
- Figure 49 : Asia Pacific Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
- Figure 50 : Asia Pacific Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
- Figure 51 : Asia Pacific Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 52 : Asia Pacific Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031
- Figure 53 : Asia Pacific Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031
- Figure 54 : Asia Pacific Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031
- Figure 55 : Latin America Orthobiologics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
- Figure 56 : Latin America Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
- Figure 57 : Latin America Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
- Figure 58 : Latin America Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
- Figure 59 : Latin America Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
- Figure 60 : Latin America Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 61 : Latin America Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031
- Figure 62 : Latin America Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031
- Figure 63 : Latin America Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031
- Figure 64 : Middle East & Africa Orthobiologics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
- Figure 65 : Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
- Figure 66 : Middle East & Africa Orthobiologics Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
- Figure 67 : Middle East & Africa Orthobiologics Market Value Share Analysis, by Product, 2017 and 2031
- Figure 68 : Middle East & Africa Orthobiologics Market Value Share Analysis, by Application, 2017 and 2031
- Figure 69 : Middle East & Africa Orthobiologics Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 70 : Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Product, 2022–2031
- Figure 71 : Middle East & Africa Orthobiologics Market Attractiveness Analysis, by Application, 2022–2031
- Figure 72 : Middle East & Africa Orthobiologics Market Attractiveness Analysis, by End-user, 2022–2031
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.
Similar Reports from Transparency
Orthobiologics Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Global Orthobiologics Market: Overview
This report analyzes the current and future scenario of the global orthobiologics market. Surge in the number of orthopedic procedures, increase in demand for biologics in spinal surgery and traumatic injuries, and rise in prevalence of chronic arthritis are projected to drive the global market. Additionally, rise in prevalence of sports injuries propels the ...
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More